Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus

NeuroToxicology

Volumn 25, Issue 5, 2004, Pages 835-847

  Peterson, Steven L ^a   Purvis, Rebecca S ^a   Griffith, James W ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

1 Aminocyclopropanecarboxylic acid; D Cycloserine; Lithium; Neuroprotection; Pilocarpine; Status epilepticus

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; ANTICONVULSIVE AGENT; CYCLOSERINE; IONOPHORE; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; PILOCARPINE; PROPOFOL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EPILEPTIC STATE; HIPPOCAMPUS; LATENT PERIOD; MALE; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEIZURE; SEIZURE THRESHOLD; THALAMUS;

AMINO ACIDS, CYCLIC; ANIMALS; ANTIMETABOLITES; BRAIN; CYCLOSERINE; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; IMAGE PROCESSING, COMPUTER-ASSISTED; LITHIUM; MALE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; NEUROPROTECTIVE AGENTS; PARASYMPATHETIC NERVOUS SYSTEM; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; STATUS EPILEPTICUS;

HEDYOTIS MANNII; STRYCHNOS TOXIFERA;

EID: 3543022155     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2004.01.003     Document Type: Article

References (60)

1. Andre A., Ferrandon A., Marescaux C., Nehlig A. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 47:2001;99-117
2. Baran H., Loscher W., Mevissen M. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam. Brain Res. 652:1994;195-200
3. Berger P., Farrel K., Sharp F., Skolnick P. Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulated cortex. Neurosci. Lett. 168:1994;147-150
4. Bisaga A., Krascik P., Jankowska E., Palejko W., Kostowski W., Danysz W. Effect of glutamate receptor antagonists on N-methyl-D-aspartate and (S)-α-amino-3-hydoxy-5-methyl-4-isoxazolepropionic acid induced convulsant effects in mice and rats. Eur. J. Pharmacol. 242:1993;213-220
5. Boje K.M., Wong G., Skolnick P. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures. Brain Res. 603:1993;207-214
6. Bonhaus D., Burge B., McNamara J. Biochemical evidence that glycine allosterically regulates an NMDA receptor-coupled ion channel. Eur. J. Pharmacol. 142:1987;489-490
7. Bowery N. Glycine binding sites and NMDA receptors in the brain. Nature. 326:1987;338
8. Chittajally R., Vignes M., Dev K.K., Barnes J.M., Collingridge G.L., Henley J.M. Regulation of glutamate release by presynaptic kainite receptors in the hippocampus. Nature. 379:1996;78-81
9. Clifford D.B., Olney J.W., Maniotis A., Collins R.C., Zorumski C.F. The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience. 23(3):1987;953-968
10. Clifford D.B., Olney J.W., Benz A.M., Fuller T.A., Zorumski C.F. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia. 31(4):1990;382-389
11. Dubé C., Boyet S., Marescaux C., Nehlig A. Progressive metabolic changes underlying the chronic reorganization of brain circuits during the silent phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 162:2000;146-157
12. Dubé C., Boyet S., Marescaux C., Nehlig A. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 167:2001;227-241
13. Ferkany J.W., Zaczek R., Coyle J.T. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature. 298:1982;757-759
14. Filbert M.G., Forster J.S., Smith C.D., Ballough G.P.H. Neuroprotective effects of HU-211 on brain damage resulting from soman-induced seizures. Ann. N.Y. Acad. Sci. 890:1999;505-514
15. Fossom L.H., Von Lubitz D.K.J.E., Lin R.C.S., Skolnick P. Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites. Neurol. Res. 17:1995;265-269
16. Fujikawa D.G. Neuroprotecitve effect of ketamine administered after status epilepticus onset. Epilepsia. 36(2):1995;186-195
17. Fujikawa D.G., Daniels A.H., Kim J.S. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 17:1994;207-219
18. Fujikawa D.G., Shinmei S.S., Cai B. Lithium-pilocarpine-induced status epilepticus produces necrotic neurons with internecleosomal DNA fragmentation in adult rats. Eur. J. Neurosci. 11:1999;1605-1614
19. Henderson G., Johnson J.W., Ascher P. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J. Physiol. 430:1990;189-212
20. Honchar M.P., Olney J.W., Sherman W.R. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science. 220:1983;323-334
21. Hood W.F., Compton R.P., Monahan J.B. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci. Lett. 98:1989;91-95
22. Hort J., Brozek G., Mares P., Langmeier M., Komarek V. Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia. 40(9):1999;1177-1183
23. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., et al. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268(4):1993;2836-2843
24. Jobe R.S., Morrisett R.A., Snead O.C. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp. Neurol. 91:1986;471-480
25. Johnson J., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531
26. Karcz-Kubicha M., Jessa M., Nazar M., Plaznik A., Hartmann S., Parsons C.G., et al. Anxiolytic activity of glycine-B antagonists and partial agonists. No relation to intrinsic activity in the patch clamp. Neuropharmacology. 36(10):1997;1355-1367
27. Kemp J.A., Foster A.C., Leeson P.D., Priestley T., Tridgett R., Iversen L.L., et al. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6547-6550
28. Kleckner N.W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241:1988;835-837
29. Kleckner N.W., Dingledine R. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Mol. Pharmacol. 36:1989;430-436
30. Liu Z., Stafstrom C.E., Sarkisian M.R., Yang Y., Hori A., Tandon P., et al. Seizure-induced glutamate release in mature and immature animals; an in vivo microdialysis study. NeuroReport. 8(8):1997;2019-2023
31. Long J.B., Skolnick P. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur. J. Pharmacol. 261:1994;295-301
32. Loscher W., Wlaz P., Rundfeldt C., Baran H., Honack D. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br. J. Pharmacol. 112:1994;97-106
33. Marvizon J.C.G., Lewin A.H., Skolnick P. 1-Aminocycloproparecarboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 52:1989;992-994
34. McDonough J.H., Shih T.M. Pharmacological modulation of soman-induced seizures. Neurosci. Biohehav. Rev. 17:1993;203-215
35. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21(5):1997;559-579
36. McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:1989;256-276
37. McDonough J.H., Clark T.R., Slone T.W., Zoeffel D., Brown K., Kim S., et al. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. NeuroToxicology. 19(3):1998;381-392
38. McLean M.J., Gupta R.C., Dettbarn W.D., Wamil A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol. 112:1992;95-103
39. Morrisett R.A., Jope R.S., Snead O.C. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp. Neurol. 97:1987;193-200
40. Motte J., da Silva Fernandes M.J., Baram T.Z., Nehlig A. Spatial and temporal evolution of neuronal activation, stress and injury in lithium-pilocarpine seizures in adult rats. Brain Res. 798:1998;61-72
41. Nahum-Levy R., Fossom L.H., Skolnick P., Benveniste M. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonists at N-methyl-D-aspartate receptors. Mol. Pharmacol. 56:1999;1207-1218
42. Newell D.W., Barth A., Ricciardi T.N., Malouf A.T. Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus. Exp. Neurol. 145:1997;235-244
43. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518
44. Ormandy G.C., Jope R.S., Snead O.C. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp. Neurol. 106:1989;172-180
45. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Orlando, FL: Academic Press; 1986.
46. Peredery O., Persinger M.A., Parker G., Mastrosov L. Temporal changes in neuronal dropout following inductions of lithium/pilocarpine seizures in the rat. Brain Res. 881:2000;9-17
47. Peterson S.L. 7-chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures. Epilepsy Res. 13:1992;73-81
48. Rigoulot M.A., Leroy C., Koning E., Ferrandon A., Mehlig A. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat. Epilepsia. 44(4):2003;529-535
49. Rogawski M.A. The NMDA receptor, NMDA antagonists, and epilepsy therapy. Drugs. 44(3):1992;279-292
50. Rong Y., Doctrow S.R., Tocco G., Baudry M. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9897-9902
51. Sheinin A., Shavit S., Benveniste M. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology. 41:2001;151-158
52. Sheinin A., Nahum-Levy R., Shavit S., Benveniste M. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid for rat N-methyl-D-aspartate receptor subunits. Neurosci. Lett. 317:2002;77-80
53. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7:1990;105-116
54. Skolnick P., Marvizon J.C.G, Jackson B.W., Monn J.A., Rice K.C., Lewin A.H. Blockade of the N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45:1989;1647-1655
55. Smith S.C., Al-Zubaidy Z.A., Chapman A.G., Meldrum B.S. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Res. 15:1993;101-111
56. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. TIPS. 18(6):1997;183-185
57. Walton N.Y., Treiman D.M. Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res. 553:1991;97-104
58. Watson G.B., Lanthorn T.H. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology. 29(8):1990;727-730
59. White HS, Woodhead JH, Franklin MR, Swinyard EA, Wolf HH. Experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy HH, Mattson RH, Meldrum BS, editors. Antiepileptic drugs. New York: Raven Press; 1995. p. 99-110.
60. B receptor ligands, D-cycloserine and L-701, 324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. Bull. 46(6):1998;535-540